Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127202412 | 12720241 | 2 | F | 20160824 | 20160912 | 20160907 | 20160921 | EXP | DE-SA-2016SA161406 | AVENTIS | 77.00 | YR | E | M | Y | 73.00000 | KG | 20160921 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127202412 | 12720241 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | STRENGTH: 75 MG | UNK | 20839 | 75 | MG | FILM-COATED TABLET | QD | |||||
| 127202412 | 12720241 | 2 | SS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | STRENGTH: 75 MG | UNK | 20839 | 75 | MG | FILM-COATED TABLET | QD | |||||
| 127202412 | 12720241 | 3 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | STRENGTH: 40 MG | Y | UNK | 0 | 40 | MG | QD | |||||
| 127202412 | 12720241 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127202412 | 12720241 | 5 | C | APIXABAN | APIXABAN | 1 | Oral | 5 MG | 0 | 5 | MG | QD | |||||||
| 127202412 | 12720241 | 6 | C | PHENPROCOUMON | PHENPROCOUMON | 1 | 0 | ||||||||||||
| 127202412 | 12720241 | 7 | C | HCT | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 12.5 | MG | QD | ||||||||
| 127202412 | 12720241 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127202412 | 12720241 | 1 | Acute coronary syndrome |
| 127202412 | 12720241 | 2 | Atrial fibrillation |
| 127202412 | 12720241 | 3 | Hypercholesterolaemia |
| 127202412 | 12720241 | 7 | Hypertension |
| 127202412 | 12720241 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127202412 | 12720241 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127202412 | 12720241 | Blood creatine phosphokinase increased | |
| 127202412 | 12720241 | Rhabdomyolysis | |
| 127202412 | 12720241 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127202412 | 12720241 | 1 | 20160729 | 0 | ||
| 127202412 | 12720241 | 2 | 20160729 | 0 | ||
| 127202412 | 12720241 | 3 | 20160824 | 0 | ||
| 127202412 | 12720241 | 5 | 20160729 | 0 |